Antibiotic lock therapy: review of technique and logistical challenges

References

• Centers for Disease Control and Prevention (CDC)Vital Signs. Making Health Care Safer: Reducing Bloodstream InfectionsAtlanta, GACenters for Disease Control and Prevention2011 Available from: http://www.cdc.gov/VitalSigns/pdf/2011-03-vitalsigns.pdfAccessed May 10, 2014
   Google Scholar
• DudeckMAWeinerLMAllen-BridsonKNational Healthcare Safety Network (NHSN) report, data summary for 2012, Device-associated moduleAm J Infect Control201341121148116624274911
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC)Vital Signs: Central line-associated bloodstream infections – United States, 2001, 2008, and 2009MMWR Morb Mortal Wkly Rep201160824324821368740
   PubMedGoogle Scholar
• Centers for Disease Control and Prevention (CDC)Guidelines for the Prevention of Intravascular Catheter-Related Infections 2011Atlanta, GACenters for Disease Control and Prevention2011 Available from: http://www.cdc.gov/hicpac/pdf/guidelines/bsi-guidelines-2011.pdfAccessed May 10, 2014
   Google Scholar
• MermelLAAllonMBouzaEClinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of AmericaClin Infect Dis200949114519489710
   PubMed Web of Science ®Google Scholar
• BustosCAguinagaACarmona-TorreFDel PozoJLLong-term catheterization: current approaches in the diagnosis and treatment of port-related infectionsInfect Drug Resist20147253524570595
   PubMed Web of Science ®Google Scholar
• CostertonJWLewandowskiZDeBeerDCaldwellDKorberDJamesGBiofilms, the customized micronicheJ Bacteriol19941768213721428157581
   PubMed Web of Science ®Google Scholar
• NicholsWWDorringtonSMSlackMPWalmsleyHLInhibition of tobramycin diffusion by binding to alginateAntimicrob Agents Chemother19883245185233132093
   PubMed Web of Science ®Google Scholar
• JeffersonKKGoldmannDAPierGBUse of confocal microscopy to analyze the rate of vancomycin penetration through Staphylococcus aureus biofilmsAntimicrob Agents Chemother20054962467247315917548
   PubMed Web of Science ®Google Scholar
• AraújoPAMergulhãoFMeloLSimõesMThe ability of an antimicrobial agent to penetrate a biofilm is not correlated with its killing or removal efficiencyBiofouling Epub2014429
   Web of Science ®Google Scholar
• AnderlJNFranklinMJStewartPSRole of antibiotic penetration limitation in Klebsiella pneumoniae biofilm resistance to ampicillin and ciprofloxacinAntimicrob Agents Chemother20004471818182410858336
   PubMed Web of Science ®Google Scholar
• BaninEBradyKMGreenbergEPChelator-induced dispersal and killing of Pseudomonas aeruginosa cells in a biofilmAppl Environ Microbiol20067232064206916517655
   PubMed Web of Science ®Google Scholar
• RaadIIFangXKeutgenXMJiangYSherertzRHachemRThe role of chelators in preventing biofilm formation and catheter-related bloodstream infectionsCurr Opin Infect Dis200821438539218594291
   PubMed Web of Science ®Google Scholar
• MaiefskiMRuppMEHermsenEDEthanol lock technique: review of the literatureInfect Control Hosp Epidemiol200930111096110819803767
   PubMed Web of Science ®Google Scholar
• JafferYSelbyNMTaalMWFluckRJMcIntyreCWA meta-analysis of hemodialysis catheter locking solutions in the prevention of catheter-related infectionAm J Kidney Dis200851223324118215701
   PubMed Web of Science ®Google Scholar
• O’HoroJCSilvaGLSafdarNAnti-infective locks for treatment of central line-associated bloodstream infection: a systematic review and meta-analysisAm J Nephrol201134541542221934302
   PubMed Web of Science ®Google Scholar
• PolgreenPMBeekmannSEDiekemaDJSherertzRJWide variability in the use of antimicrobial lock therapy and prophylaxis among infectious diseases consultantsInfect Control Hosp Epidemiol201031555455720334551
   PubMed Web of Science ®Google Scholar
• SaxenaAKPanhotraBRNaguibMSudden irreversible sensory-neural hearing loss in a patient with diabetes receiving amikacin as an antibiotic-heparin lockPharmacotherapy200222110510811794420
   PubMed Web of Science ®Google Scholar
• RaoJSO’MearaAHarveyTBreatnachFA new approach to the management of Broviac catheter infectionJ Hosp Infect19922221091161358952
   PubMed Web of Science ®Google Scholar
• OnderAMChandarJBillingsAAComparison of early versus late use of antibiotic locks in the treatment of catheter-related bacteremiaClin J Am Soc Nephrol2008341048105618400965
   PubMed Web of Science ®Google Scholar
• PooleCVCarltonDBimboLAllonMTreatment of catheter-related bacteraemia with an antibiotic lock protocol: effect of bacterial pathogenNephrol Dial Transplant20041951237124414993504
   PubMed Web of Science ®Google Scholar
• Haimi-CohenYHusainNMeenanJKarayalcinGLehrerMRubinLGVancomycin and ceftazidime bioactivities persist for at least 2 weeks in the lumen in ports: simplifying treatment of port-associated bloodstream infections by using the antibiotic lock techniqueAntimicrob Agents Chemother20014551565156711302830
   PubMed Web of Science ®Google Scholar
• AnthonyTURubinLGStability of antibiotics used for antibiotic-lock treatment of infections of implantable venous devices (ports)Antimicrob Agents Chemother19994382074207610428941
   PubMed Web of Science ®Google Scholar
• RobinsonJLTawfikGSaxingerLStangLEtchesWLeeBStability of heparin and physical compatibility of heparin/antibiotic solutions in concentrations appropriate for antibiotic lock therapyJ Antimicrob Chemother200556595195316155063
   PubMed Web of Science ®Google Scholar
• BoorguRDubrowAJLevinNWAdjunctive antibiotic/lock therapy in the treatment of bacteremia associated with the use of a subcutaneously implanted hemodialysis access deviceASAIO J200046676777011110278
   PubMed Web of Science ®Google Scholar
• SantarpiaLPasanisiFAlfonsiLPrevention and treatment of implanted central venous catheter (CVC) – related sepsis: a report after six years of home parenteral nutrition (HPN)Clin Nutr200221320721112127928
   PubMed Web of Science ®Google Scholar
• Del PozoJLAlonsoMSerreraAHernaezSAguinagaALeivaJEffectiveness of the antibiotic lock therapy for the treatment of port-related enterococci, Gram-negative, or Gram-positive bacilli bloodstream infectionsDiagn Microbiol Infect Dis200963220821219026506
   PubMed Web of Science ®Google Scholar
• LeeMYKoKSSongJHPeckKRIn vitro effectiveness of the antibiotic lock technique (ALT) for the treatment of catheter-related infections by Pseudomonas aeruginosa and Klebsiella pneumoniaeJ Antimicrob Chemother200760478278717681978
   PubMed Web of Science ®Google Scholar
• LeeHRLeeYKSongYLTreatment of catheter-related bacteremia with an antibiotic lock protocol in hemodialysis patientsKorean J Nephrol2005246903911 Korean
   Google Scholar
• SaxingerLWilliamsKLyonMMochurokMStability of antibiotics in heparin at 37°C: towards antibiotic locks for central venous catheter related infectionsProgramme and Abstracts of the 39th Interscience Conference on Antimicrobial Agents and ChemotherapySeptember 26–29, 1999San Francisco, CA
   Google Scholar
• BookstaverPBRokasKENorrisLBEdwardsJMSherertzRJStability and compatibility of antimicrobial lock solutionsAm J Health Syst Pharm201370242185219824296841
   PubMed Web of Science ®Google Scholar
• BastaniBThe myth of incompatibility of gentamicin and heparin revisitedJ Nephrol201124219219520623465
   PubMed Web of Science ®Google Scholar
• ZhaoYLiZZhangLCitrate versus heparin lock for hemodialysis catheters: a systematic review and meta-analysis of randomized controlled trialsAm J Kidney Dis201463347949024125729
   PubMed Web of Science ®Google Scholar
• DotsonBLynnSSavakisKChurchwellMDPhysical compatibility of 4% sodium citrate with selected antimicrobial agentsAm J Health Syst Pharm201067141195119820592327
   PubMed Web of Science ®Google Scholar
• OnderAMChandarJSimonNComparison of tissue plasminogen activator-antibiotic locks with heparin-antibiotic locks in children with catheter-related bacteraemiaNephrol Dial Transplant20082382604261018332071
   PubMed Web of Science ®Google Scholar
• OnderAMChandarJBillingsAProphylaxis of catheter-related bacteremia using tissue plasminogen activator-tobramycin locksPediatr Nephrol200924112233224319590902
   PubMed Web of Science ®Google Scholar
• SofroniadouSRevelaISmirloglouDLinezolid versus vancomycin antibiotic lock solution for the prevention of nontunneled catheter-related blood stream infections in hemodialysis patients: a prospective randomized studySemin Dial201225334435022074188
   PubMed Web of Science ®Google Scholar
• DrosteJCJerajHAMacDonaldAFarringtonKStability and in vitro efficacy of antibiotic-heparin lock solutions potentially useful for treatment of central venous catheter-related sepsisJ Antimicrob Chemother200351484985512654743
   PubMed Web of Science ®Google Scholar
• LaPlanteKLWoodmanseeSMermelLACompatibility and stability of telavancin and vancomycin in heparin or sodium citrate lock solutionsAm J Health Syst Pharm201269161405140922855107
   PubMed Web of Science ®Google Scholar
• MessingBPeitra-CohenSDebureABeliahMBernierJJAntibiotic-lock technique: a new approach to optimal therapy for catheter-related sepsis in home-parenteral nutrition patientsJPEN J Parenter Enteral Nutr19881221851893129594
   PubMed Web of Science ®Google Scholar
• ChatzinikolaouIZipfTFHannaHMinocycline-ethylenediaminetetraacetate lock solution for the prevention of implantable port infections in children with cancerClin Infect Dis200336111611912491212
   PubMed Web of Science ®Google Scholar
• FeelyTCopleyABleyerAJCatheter lock solutions to prevent bloodstream infections in high-risk hemodialysis patientsAm J Nephrol2007271242917215571
   PubMed Web of Science ®Google Scholar
• CamposRPdo NascimentoMMChulaDCRiellaMCMinocycline-EDTA lock solution prevents catheter-related bacteremia in hemodialysisJ Am Soc Nephrol201122101939194521852579
   PubMed Web of Science ®Google Scholar
• NoriUSManoharanAYeeJBesarabAComparison of low-dose gentamicin with minocycline as catheter lock solutions in the prevention of catheter-related bacteremiaAm J Kidney Dis200648459660516997056
   PubMed Web of Science ®Google Scholar
• BookstaverPBWilliamsonJCTuckerBKRaadIISherertzRJActivity of novel antibiotic lock solutions in a model against isolates of catheter-related bloodstream infectionsAnn Pharmacother200943221021919193593
   PubMed Web of Science ®Google Scholar
• VincentelliJBraguerDGuilletPFormulation of a flush solution of heparin, vancomycin, and colistin for implantable access systems in oncologyJ Oncol Pharm Pract1997311823
   Google Scholar
• OzbekBMataraciEIn vitro effectiveness of colistin, tigecycline and levofloxacin alone and combined with clarithromycin and/or heparin as lock solutions against embedded Acinetobacter baumannii strainsJ Antimicrob Chemother201368482783023203948
   PubMed Web of Science ®Google Scholar
• BookstaverPPremnathPEdwardsJEvaluation of compatibility and stability of daptomycin in an antibiotic-anticoagulant lock solutionAmerican College of Clinical Pharmacy Annual MeetingOctober 21–24, 2012Hollywood, FL
   Google Scholar
• MakiDGAshSRWingerRKLavinPAZEPTIC Trial InvestigatorsA novel antimicrobial and antithrombotic lock solution for hemodialysis catheters: a multi-center, controlled, randomized trialCrit Care Med201139461362021200319
   PubMed Web of Science ®Google Scholar
• RaadIBodeyGPNovel antimicrobial catheter lock solution: a new direction in which chelators replace heparinCrit Care Med201139487587621613829
   PubMed Web of Science ®Google Scholar
• DiMondiPVTownsendMLJohnsonMDurkinMAntifungal catheter lock therapy for the management of a persistent Candida albicans bloodstream infection in an adult receiving hemodialysisPharmacotherapy2014347e120e12724782326
   PubMed Web of Science ®Google Scholar
• VanholderRCanaudBFluckRDiagnosis, prevention and treatment of haemodialysis catheter-related bloodstream infections (CRBSI): a position statement of European Renal Best Practice (ERBP)NDT Plus201033234246
   Google Scholar
• PierceDARoccoMVTrisodium citrate: an alternative to unfractionated heparin for hemodialysis catheter dwellsPharmacotherapy201030111150115820973688
   PubMed Web of Science ®Google Scholar
• MD Anderson Cancer CenterTriaxAntimicrobial catheter lock solution for the treatment of central line associated bloodstream infection (CLABSI) Available from: http://clinicaltrials.gov/ct2/show/NCT1539343. NLM identifier: NCT1539343Accessed June 20, 2014
   Google Scholar
• LexiCompEdetate Calcium Disodium, Calcium EDTA [Drug Monograph]2009 Available from: http://online.lexi.com/lco/action/doc/retrieve/docid/250/413457#synlistAccessed June 20, 2014
   Google Scholar
• US Food and Drug AdministrationPublic health advisory: edetate disodium (marketed as Endrate and generic products)2008 Available from: http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm051138.htmAccessed June 20, 2014
   Google Scholar
• US Food and Drug AdministrationWarning on Tricitrasol Dialysis Catheter Anticoagulant. FDA Talk PaperRockville, MDPublic Health Service200016414-2000
   Google Scholar
• PuntCDBoerWECardiac arrest following injection of concentrated trisodium citrateClin Nephrol200869431731818397711
   PubMed Web of Science ®Google Scholar
• WillicombeMKVernonKDavenportAEmbolic complications from central venous hemodialysis catheters used with hypertonic citrate locking solutionAm J Kidney Dis201055234835119800723
   PubMed Web of Science ®Google Scholar
• SchilcherGScharnaglHHorinaJHTrisodium citrate induced protein precipitation in haemodialysis catheters might cause pulmonary embolismNephrol Dial Transplant20122772953295722467258
   PubMed Web of Science ®Google Scholar
• Tauro-Implant GmbH [webpage on the Internet]FAQTauroLock Antimicrob Catheter Lock Syst Provide Patency Infect Control2010 Available from: http://www.taurolock.com/en/faqAccessed June 20, 2014
   Google Scholar
• Dirinco [webpage on the Internet]FAQsCitra-Lock Catheter Lock Solut2013 Available from: http://www.citra-lock.com/index.php/en/science-behind/faqs.html#4-what-are-the-side-effects-of-citra-lockAccessed June 20, 2014
   Google Scholar
• CoteDLokCEBattistellaMVercaigneLStability of trisodium citrate and gentamicin solution for catheter locks after storage in plastic syringes at room temperatureCan J Hosp Pharm201063430431122478993
   PubMedGoogle Scholar
• BookstaverPBGerraldKRMoranRRClinical outcomes of antimicrobial lock solutions used in a treatment modality: a retrospective case series analysisClin Pharmacol Adv Appl20102123130
   PubMedGoogle Scholar
• TendasANiscolaPCupelliLControversies on antibiotic lock technique duration: experience with a 3-day course for hematological patientsInfect Control Hosp Epidemiol201132440841021460500
   PubMed Web of Science ®Google Scholar
• Sánchez-MuñozAAguadoJMLópez-MartínAUsefulness of antibiotic-lock technique in management of oncology patients with uncomplicated bacteremia related to tunneled cathetersEur J Clin Microbiol Infect Dis200524429129315902539
   PubMed Web of Science ®Google Scholar
• Segarra-NewnhamMMartin-CooperEMAntibiotic lock technique: a review of the literatureAnn Pharmacother200539231131815623848
   PubMed Web of Science ®Google Scholar
• Fernandez-HidalgoNAlmiranteBCallejaRAntibiotic-lock therapy for long-term intravascular catheter-related bacteraemia: results of an open, non-comparative studyJ Antimicrob Chemother20065761172118016597634
   PubMed Web of Science ®Google Scholar
• RaadIHannaHDvorakTChaibanGHachemROptimal antimicrobial catheter lock solution, using different combinations of minocycline, EDTA, and 25-percent ethanol, rapidly eradicates organisms embedded in biofilmAntimicrob Agents Chemother2007511788317074799
   PubMed Web of Science ®Google Scholar
• MessingBManFColimonRThuillierFBeliahMAntibiotic-lock technique is an effective treatment of bacterial catheter-related sepsis during parenteral nutritionClin Nutr19909422022516837359
   PubMed Web of Science ®Google Scholar
• YevzlinASSanchezRJHiattJGConcentrated heparin lock is associated with major bleeding complications after tunneled hemodialysis catheter placementSemin Dial200720435135417635828
   PubMed Web of Science ®Google Scholar
• AbbasSAHaloobIATaylorSLEffect of antimicrobial locks for tunneled hemodialysis catheters on bloodstream infection and bacterial resistance: a quality improvement reportAm J Kidney Dis200953349250219150156
   PubMed Web of Science ®Google Scholar
• LandryDLBradenGLGobeilleSLHaesslerSDVaidyaCKSweetSJEmergence of gentamicin-resistant bacteremia in hemodialysis patients receiving gentamicin lock catheter prophylaxisClin J Am Soc Nephrol20105101799180420595689
   PubMed Web of Science ®Google Scholar
• WaltersMC3rdRoeFBugnicourtAFranklinMJStewartPSContributions of antibiotic penetration, oxygen limitation, and low metabolic activity to tolerance of Pseudomonas aeruginosa biofilms to ciprofloxacin and tobramycinAntimicrob Agents Chemother200347131732312499208
   PubMed Web of Science ®Google Scholar
• ShigetaMTanakaGKomatsuzawaHSugaiMSuginakaHUsuiTPermeation of antimicrobial agents through Pseudomonas aeruginosa biofilms: a simple methodChemotherapy19974353403459309367
   PubMed Web of Science ®Google Scholar
• SinghRRayPDasASharmaMPenetration of antibiotics through Staphylococcus aureus and Staphylococcus epidermidis biofilmsJ Antimicrob Chemother20106591955195820615927
   PubMed Web of Science ®Google Scholar
• DunneWMJrMasonEOJrKaplanSLDiffusion of rifampin and vancomycin through a Staphylococcus epidermidis biofilmAntimicrob Agents Chemother19933712252225268109913
   PubMed Web of Science ®Google Scholar
• ZhengZStewartPSPenetration of rifampin through Staphylococcus epidermidis biofilmsAntimicrob Agents Chemother200246390090311850284
   PubMed Web of Science ®Google Scholar
• Rodríguez-MartínezJMBallestaSGarcíaIConejoMCPascualAActividad y permeabilidad de linezolid y vancomicina en biocapas de Staphylococcus epidermidis [Activity and penetration of linezolid and vancomycin against Staphylococcus epidermidis biofilms]Enferm Infecc Microbiol Clin2007257425428 Spanish17692209
   PubMed Web of Science ®Google Scholar
• StewartPSDavisonWMSteenbergenJNDaptomycin rapidly penetrates a Staphylococcus epidermidis biofilmAntimicrob Agents Chemother20095383505350719451285
   PubMed Web of Science ®Google Scholar
• LinMHeLGaoJPenetration of erythromycin through Staphylococcus epidermidis biofilmChin Med J (Engl)2013126142647265123876889
   PubMed Web of Science ®Google Scholar
• HoyleBDAlcantaraJCostertonJWPseudomonas aeruginosa biofilm as a diffusion barrier to piperacillinAntimicrob Agents Chemother1992369205420561416900
   PubMed Web of Science ®Google Scholar
• DarouicheRODhirAMillerAJLandonGCRaadIIMusherDMVancomycin penetration into biofilm covering infected prostheses and effect on bacteriaJ Infect Dis199417037207237915751
   PubMed Web of Science ®Google Scholar
• RobinsonJLTawfikGRothABarriers to antibiotic lock therapy in children with intravascular catheter-related bloodstream infectionsPediatr Infect Dis J2005241094416220107
   PubMed Web of Science ®Google Scholar
• ElwoodRLSpencerSESuccessful clearance of catheter-related bloodstream infection by antibiotic lock therapy using ampicillinAnn Pharmacother200640234735016449537
   PubMed Web of Science ®Google Scholar
• KrzywdaEAAndrisDAEdmistonCEQuebbemanEJTreatment of Hickman catheter sepsis using antibiotic lock techniqueInfect Control Hosp Epidemiol199516105965988568206
   PubMed Web of Science ®Google Scholar
• DavanipurMPakfetratMRoozbehJCloxacillin as an antibiotic lock solution for prevention of catheter-associated infectionIran J Kidney Dis20115532833121876310
   PubMed Web of Science ®Google Scholar
• JohnsonDCJohnsonFLGoldmanSPreliminary results treating persistent central venous catheter infections with the antibiotic lock technique in pediatric patientsPediatr Infect Dis J199413109309317854895
   PubMed Web of Science ®Google Scholar
• SilvaTNVMendesMLAbrãoJMGCaramoriJTPonceDSuccessful prevention of tunneled central catheter infection by antibiotic lock therapy using cefazolin and gentamicinInt Urol Nephrol20134551405141323269457
   PubMed Web of Science ®Google Scholar
• ChauhanALebeauxDDecanteBA rat model of central venous catheter to study establishment of long-term bacterial biofilm and related acute and chronic infectionsPLoS One201275e3728122615964
   PubMed Web of Science ®Google Scholar
• MayaIDCarltonDEstradaEAllonMTreatment of dialysis catheter-related Staphylococcus aureus bacteremia with an antibiotic lock: a quality improvement reportAm J Kidney Dis200750228929517660030
   PubMed Web of Science ®Google Scholar
• ChiouPFChangCCWenYKYangYAntibiotic lock technique reduces the incidence of temporary catheter-related infectionsClin Nephrol200665641942216792137
   PubMed Web of Science ®Google Scholar
• KimSHSongKIChangJWPrevention of uncuffed hemodialysis catheter-related bacteremia using an antibiotic lock technique: a prospective, randomized clinical trialKidney Int200669116116416374438
   PubMed Web of Science ®Google Scholar
• VercaigneLMZelenitskySAFindlayIBernsteinKPennerSBAn in vitro evaluation of the antibiotic/heparin lock to sterilize central venous haemodialysis cathetersJ Antimicrob Chemother200249469369611909847
   PubMed Web of Science ®Google Scholar
• VercaigneLMSitarDSPennerSBBernsteinKWangGQBurczynskiFJAntibiotic-heparin lock: in vitro antibiotic stability combined with heparin in a central venous catheterPharmacotherapy200020439439910772369
   PubMed Web of Science ®Google Scholar
• KrishnasamiZCarltonDBimboLManagement of hemodialysis catheter-related bacteremia with an adjunctive antibiotic lock solutionKidney Int20026131136114211849468
   PubMed Web of Science ®Google Scholar
• ShahJFeinfeldDAUse of ‘locked-in’ antibiotic to treat an unusual gram-negative hemodialysis catheter infectionNephron200085434835010940747
   PubMed Web of Science ®Google Scholar
• LeeYKKimJKOhSELeeJNohJWSuccessful antibiotic lock therapy in patients with refractory peritonitisClin Nephrol200972648849119954727
   PubMed Web of Science ®Google Scholar
• SaxenaAKPanhotraBRThe impact of catheter-restricted filling with cefotaxime and heparin on the lifespan of temporary hemodialysis catheters: a case controlled studyJ Nephrol200518675576316358235
   PubMed Web of Science ®Google Scholar
• SaxenaAKPanhotraBRSundaramDSMorsyMNAl-GhamdiAMEnhancing the survival of tunneled haemodialysis catheters using an antibiotic lock in the elderly: a randomised, double-blind clinical trialNephrology (Carlton)200611429930516889569
   PubMed Web of Science ®Google Scholar
• SaxenaAKPanhotraBRSundaramDSTunneled catheters’ outcome optimization among diabetics on dialysis through antibiotic-lock placementKidney Int20067091629163516955110
   PubMed Web of Science ®Google Scholar
• SaxenaAKPanhotraBRAl-hafizAASundaramDSAbu-OyunBAl MulhimKCefotaxime-heparin lock prophylaxis against hemodialysis catheter-related sepsis among Staphylococcus aureus nasal carriersSaudi J Kidney Dis Transpl201223474375422805387
   PubMedGoogle Scholar
• MortazaviMAlsaeidiSSobhaniRSuccessful prevention of tunneled, central catheter infection by antibiotic lock therapy using cefotaximeJ Res Med Sci201116330330922091249
   PubMed Web of Science ®Google Scholar
• BakerDSWaldropBArnoldJCompatibility and stability of cefotaxime, vancomycin, and ciprofloxacin in antibiotic lock solutions containing heparinInt J Pharm Compd201014434634923965543
   PubMedGoogle Scholar
• CapdevilaJASegarraAPlanesAMSuccessful treatment of haemodialysis catheter-related sepsis without catheter removalNephrol Dial Transplant1993832312348385290
   PubMed Web of Science ®Google Scholar
• CapdevilaJAGavaldàJForteaJLack of antimicrobial activity of sodium heparin for treating experimental catheter-related infection due to Staphylococcus aureus using the antibiotic-lock techniqueClin Microbiol Infect20017420621211422243
   PubMed Web of Science ®Google Scholar
• MessingBCatheter-sepsis during home parenteral nutrition: use of the antibiotic-lock techniqueNutrition19981454664689614314
   PubMed Web of Science ®Google Scholar
• DomingoPFontanetASánchezFAllendeLVazquezGMorbidity associated with long-term use of totally implantable ports in patients with AIDSClin Infect Dis199929234635110476740
   PubMed Web of Science ®Google Scholar
• CesaroSCavaliereMSpillerMA simplified method of antibiotic lock therapy for Broviac-Hickman catheters using a CLC 2000 connector deviceSupport Care Cancer2007151959916816960
   PubMed Web of Science ®Google Scholar
• BastaniBAminKHerrAProlonged stability of stored vancomycin, gentamicin, and heparin for use in the antibiotic-lock techniqueASAIO J200551676176316340364
   PubMed Web of Science ®Google Scholar
• BattistellaMVercaigneLMCoteDLokCEAntibiotic lock: in vitro stability of gentamicin and sodium citrate stored in dialysis catheters at 37 degrees CHemodial Int201014332232620345391
   PubMed Web of Science ®Google Scholar
• OnderAMKatoTSimonNPrevention of catheter-related bacteremia in pediatric intestinal transplantation/short gut syndrome children with long-term central venous cathetersPediatr Transplant2007111879317239129
   PubMed Web of Science ®Google Scholar
• CastagnolaEMoroniCGandulliaPCatheter lock and systemic infusion of linezolid for treatment of persistent Broviac catheter-related staphylococcal bacteremiaAntimicrob Agents Chemother20065031120112116495284
   PubMed Web of Science ®Google Scholar
• HenricksonKJPowellKRSchwartzCLA dilute solution of vancomycin and heparin retains antibacterial and anticoagulant activitiesJ Infect Dis198815736006013343531
   PubMed Web of Science ®Google Scholar
• YaoJDArkinCFKarchmerAWVancomycin stability in heparin and total parenteral nutrition solutions: novel approach to therapy of central venous catheter-related infectionsJPEN J Parenter Enteral Nutr19921632682741501359
   PubMed Web of Science ®Google Scholar
• SorianoABregadaEMarquésJMDecreasing gradient of antibiotic concentration in the lumen of catheters locked with vancomycinEur J Clin Microbiol Infect Dis200726965966117629756
   PubMed Web of Science ®Google Scholar
• BattistellaMWalkerSLawSLokCAntibiotic lock: in vitro stability of vancomycin and four percent sodium citrate stored in dialysis catheters at 37 degrees CHemodial Int200913332232819493023
   PubMed Web of Science ®Google Scholar
• SafdarNMakiDGUse of vancomycin-containing lock or flush solutions for prevention of bloodstream infection associated with central venous access devices: a meta-analysis of prospective, randomized trialsClin Infect Dis200643447448416838237
   PubMed Web of Science ®Google Scholar
• DixonJJSteeleMMakanjuolaADAnti-microbial locks increase the prevalence of Staphylococcus aureus and antibiotic-resistant Enterobacter: observational retrospective cohort studyNephrol Dial Transplant20122793575358122513704
   PubMed Web of Science ®Google Scholar
• FortúnJGrillFMartín-DávilaPTreatment of long-term intravascular catheter-related bacteraemia with antibiotic-lock therapyJ Antimicrob Chemother200658481682116899468
   PubMed Web of Science ®Google Scholar
• BeigiAAKhansoltaniSMasoudpourHAtapourAAEshaghianAKhademiEFInfluence of intralumenal and antibiotic-lock of vancomycin on the rate of catheter removal in the patients with permanent hemodialysis cathetersSaudi J Kidney Dis Transplant20102115458
   Google Scholar
• Del PozoJLAguinagaAGarcia-FernandezNIntra-catheter leukocyte culture to monitor hemodialysis catheter colonization. A prospective study to prevent catheter-related bloodstream infectionsInt J Artif Organs200831982082618924094
   PubMed Web of Science ®Google Scholar
• CuntzDMichaudLGuimberDHussonMOGottrandFTurckDLocal antibiotic lock for the treatment of infections related to central catheters in parenteral nutrition in childrenJPEN J Parenter Enteral Nutr200226210410811871733
   PubMed Web of Science ®Google Scholar
• Van PraaghADGLiTZhangSDaptomycin antibiotic lock therapy in a rat model of staphylococcal central venous catheter biofilm infectionsAntimicrob Agents Chemother20115594081408921709082
   PubMed Web of Science ®Google Scholar
• OrtegaRSalmerón-GarcíaACabezaJCapitán-VallveyLFNavasNStability of daptomycin 5 mg/mL and heparin sodium 100 units/mL combined in lactated Ringer’s injection and stored in polypropylene syringes at 4 and −20°CAm J Health Syst Pharm2014711195695924831000
   PubMed Web of Science ®Google Scholar
• Del PozoJLRodilRAguinagaADaptomycin lock therapy for grampositive long-term catheter-related bloodstream infectionsInt J Clin Pract201266330530822340450
   PubMed Web of Science ®Google Scholar
• EstesRTheuschJBeckAPitrakDMullaneKMActivity of daptomycin with or without 25 percent ethanol compared to combinations of minocycline, EDTA, and 25 percent ethanol against methicillin-resistant Staphylococcus aureus isolates embedded in biofilmAntimicrob Agents Chemother20135741998200023403427
   PubMed Web of Science ®Google Scholar
• Al AkhrassFHachemRMohamedJACentral venous catheter-associated Nocardia bacteremia in cancer patientsEmerg Infect Dis20111791651165821888790
   PubMed Web of Science ®Google Scholar
• RaadIHachemRTcholakianRKSherertzREfficacy of minocycline and EDTA lock solution in preventing catheter-related bacteremia, septic phlebitis, and endocarditis in rabbitsAntimicrob Agents Chemother200246232733211796338
   PubMed Web of Science ®Google Scholar
• AslamSTrautnerBWRamanathanVDarouicheROPilot trial of N-acetylcysteine and tigecycline as a catheter-lock solution for treatment of hemodialysis catheter-associated bacteremiaInfect Control Hosp Epidemiol200829989489718643743
   PubMed Web of Science ®Google Scholar
• BartalesiFVelociSBaragliFSuccessful tigecycline lock therapy in a Lactobacillus rhamnosus catheter-related bloodstream infectionInfection201240333133422005933
   PubMed Web of Science ®Google Scholar
• GhannoumMAIshamNJacobsMRAntimicrobial activity of B-Lock against bacterial and Candida spp. causing catheter-related bloodstream infectionsAntimicrob Agents Chemother20115594430443121730123
   PubMed Web of Science ®Google Scholar